Bridgeway Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ARMP
MAM
DIG
Bridgeway Capital Management's ARMP Position: Q2 2026 in Review
Bridgeway Capital Management held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 44,682 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #983.
Bridgeway Capital Management first reported a position in ARMP in Q1 2021 and has held it in 22 quarters since. The position peaked at $623K in Q4 2021. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.
- Bridgeway Capital Management held 44,682 shares of Armata Pharmaceuticals worth $290K as of Q2 2026.
- Bridgeway Capital Management left its Armata Pharmaceuticals share count unchanged in Q2 2026.
- Armata Pharmaceuticals made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #983 holding.
- Bridgeway Capital Management first reported a position in Armata Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
- Bridgeway Capital Management's Armata Pharmaceuticals position peaked at $623K in Q4 2021.
- 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.
Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.